Identification of sulfonylpyrimidines as novel selective aldosterone synthase (CYP11B2) inhibitors

IF 3.3 3区 医学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Bioorganic & Medicinal Chemistry Pub Date : 2024-06-04 DOI:10.1016/j.bmc.2024.117775
Masaki Meguro , Satoru Miyauchi , Yukiko Kanao-Arisumi , Satoru Naito , Kanae Suzuki , Shinichi Inoue , Keisuke Yamada , Tsuyoshi Homma , Kiyoshi Chiba , Futoshi Nara , Shinji Furuzono
{"title":"Identification of sulfonylpyrimidines as novel selective aldosterone synthase (CYP11B2) inhibitors","authors":"Masaki Meguro ,&nbsp;Satoru Miyauchi ,&nbsp;Yukiko Kanao-Arisumi ,&nbsp;Satoru Naito ,&nbsp;Kanae Suzuki ,&nbsp;Shinichi Inoue ,&nbsp;Keisuke Yamada ,&nbsp;Tsuyoshi Homma ,&nbsp;Kiyoshi Chiba ,&nbsp;Futoshi Nara ,&nbsp;Shinji Furuzono","doi":"10.1016/j.bmc.2024.117775","DOIUrl":null,"url":null,"abstract":"<div><p>4-[(5-[2-Methyl-5-(methylsulfonyl)pentan-2-yl]sulfonylpyrimidin-4-yl)amino]benzonitrile <strong>2</strong> was identified as a novel potent aldosterone synthase inhibitor. Compound <strong>2</strong> was found to inhibit human CYP11B2 in the nanomolar range, and showed an aldosterone-lowering effect in a furosemide-treated cynomolgus monkey model. Although human CYP11B2 has the high homology sequence with human CYP11B1, compound <strong>2</strong> showed more than 80 times higher selectivity over human CYP11B1 in vitro.</p></div>","PeriodicalId":255,"journal":{"name":"Bioorganic & Medicinal Chemistry","volume":null,"pages":null},"PeriodicalIF":3.3000,"publicationDate":"2024-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioorganic & Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0968089624001895","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

4-[(5-[2-Methyl-5-(methylsulfonyl)pentan-2-yl]sulfonylpyrimidin-4-yl)amino]benzonitrile 2 was identified as a novel potent aldosterone synthase inhibitor. Compound 2 was found to inhibit human CYP11B2 in the nanomolar range, and showed an aldosterone-lowering effect in a furosemide-treated cynomolgus monkey model. Although human CYP11B2 has the high homology sequence with human CYP11B1, compound 2 showed more than 80 times higher selectivity over human CYP11B1 in vitro.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
鉴定磺酰基嘧啶类新型选择性醛固酮合成酶(CYP11B2)抑制剂
研究发现,4-[(5-[2-甲基-5-(甲磺酰基)戊-2-基]磺酰基嘧啶-4-基)氨基]苯腈 2 是一种新型强效醛固酮合成酶抑制剂。研究发现,化合物 2 对人类 CYP11B2 的抑制作用在纳摩尔范围内,并在呋塞米处理的猴模型中显示出降低醛固酮的作用。虽然人 CYP11B2 与人 CYP11B1 具有高同源性序列,但化合物 2 在体外的选择性比人 CYP11B1 高 80 多倍。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Bioorganic & Medicinal Chemistry
Bioorganic & Medicinal Chemistry 医学-生化与分子生物学
CiteScore
6.80
自引率
2.90%
发文量
413
审稿时长
17 days
期刊介绍: Bioorganic & Medicinal Chemistry provides an international forum for the publication of full original research papers and critical reviews on molecular interactions in key biological targets such as receptors, channels, enzymes, nucleotides, lipids and saccharides. The aim of the journal is to promote a better understanding at the molecular level of life processes, and living organisms, as well as the interaction of these with chemical agents. A special feature will be that colour illustrations will be reproduced at no charge to the author, provided that the Editor agrees that colour is essential to the information content of the illustration in question.
期刊最新文献
A methamphetamine vaccine using short monoamine and diamine peptide linkers and poly-mannose Research progress of BRD4 in head and neck squamous cell carcinoma: Therapeutic application of novel strategies and mechanisms Design, synthesis and biological evaluation of novel diphenylamine analogues as NLRP3 inflammasome inhibitors Synthesis of phenanthridine derivatives by a water-compatible gold-catalyzed hydroamination Current pharmacophore based approaches for the development of new anti-Alzheimer’s agents
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1